Therapeutics Acquisition Corp. Contracts & Agreements

62 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Incentive Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Agreement and Plan of Merger, dated as of October 2, 2023, by and among Eli Lilly and Company, Yosemite Falls Acquisition Corporation and POINT Biopharma Global Inc
Merger Agreements
Therapeutics Acquisition Corp.
2023
Amendment No. 1 dated April 17, 2023 to Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
2023
Amendment No. 2 dated April 17, 2023 to Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
2023
Form of Performance Stock Unit Award under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
Biotechnology
2023
First Amendment dated November 8, 2022 to the Exclusive License and Commercialization Agreement dated December 16, 2020 between POINT; the Canadian Molecular Probe Consortium; the...
License Agreements
Therapeutics Acquisition Corp.
2023
Purchase Agreement dated September 13, 2022 by and among the Company, Piper Sandler & Co. and Guggenheim Securities, LLC
Purchase Agreements
Therapeutics Acquisition Corp.
Biotechnology
NY
2022
Fourth Amendment dated May 6, 2022 to Exclusive Sublicense Agreement dated April 2, 2020
Therapeutics Acquisition Corp.
2022
Description of Securities
Therapeutics Acquisition Corp.
Biotechnology
2022
Employment Agreement effective December 1, 2021, as amended, by and between POINT Biopharma USA Inc. and Justyna Kelly
Employment Agreements
Therapeutics Acquisition Corp.
Biotechnology
IN
2022
Consulting Agreement effective January 1, 2022 by and between POINT Biopharma Inc. and Dr. Neil Fleshner
Consulting Agreements
Therapeutics Acquisition Corp.
2022
Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
2022
Revised Form of Non
Therapeutics Acquisition Corp.
Biotechnology
2021
Revised Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Revised Form of
Therapeutics Acquisition Corp.
2021
Exclusive Sublicense Agreement, dated April 2, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
First Amendment to Exclusive Sublicense Agreement, dated April 14, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
2021
Second Amendment to Exclusive Sublicense Agreement, dated January 5, 2021 to be effective as of December 31, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Third Amendment to Exclusive Sublicense Agreement, dated September 24, 2021, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees)
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
2021
Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors)
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
2021
Form of Indemnification Agreement
Indemnification Agreements
Therapeutics Acquisition Corp.
2021
Amended and Restated Registration and Stockholder Rights Agreement, dated June 30, 2021, by and among Therapeutics Acquisition Holdings LLC and the stockholders party thereto
Registration Rights Agreements
Therapeutics Acquisition Corp.
Biotechnology
NY
2021
POINT Biopharma Global Inc. 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
2021
Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees)
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors)
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
2021
2020 POINT Biopharma, Inc. Equity Incentive Plan
Bonus & Incentive Agreements
Therapeutics Acquisition Corp.
2021
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Allan Silber, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
2021
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Joe McCann, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Employment Agreement, dated as of July 24, 2020, by and between POINT Biopharma Corp. and William Demers, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Michael Gottlieb, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
2021
Consulting Agreement by and between POINT Biopharma Inc. and Dr. Neil Fleshner, dated February 22, 2021
Consulting Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma USA Inc. and Todd Hockemeyer
Employment Agreements
Therapeutics Acquisition Corp.
2021
Employment Agreement, dated as of July 19, 2020, by and between POINT Biopharma USA Inc. and Jessica Jensen
Employment Agreements
Therapeutics Acquisition Corp.
2021
Employment Agreement, dated as of November 2, 2020, by and between POINT Biopharma Corp. and Justyna Kelly, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Ari Shomair, as amended March 8, 2021
Employment Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Exclusive License and Commercialization Agreement, dated December 16, 2020, by and between POINT Biopharma Inc., Canadian Molecular Probe Consortium, the Centre for Probe...
License Agreements
Therapeutics Acquisition Corp.
Biotechnology
2021
Loan and Security Agreement, dated as of July 10, 2020, by and between West 78th Street, LLC and CIBC Bank USA
Loan Agreements
Therapeutics Acquisition Corp.
Biotechnology
IN
2021
Employment Agreement, dated as of March 9, 2021, by and between POINT Biopharma Corp. and Donna Husack
Employment Agreements
Therapeutics Acquisition Corp.
2021
Description of the Companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Therapeutics Acquisition Corp.
2021
Underwriting Agreement, dated July 7, 2020, by and among the Company and Jefferies LLC
Underwriting Agreements
Therapeutics Acquisition Corp.
2020
Investment Management Trust Agreement, dated July 7, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee
Stock Agreements
Therapeutics Acquisition Corp.
Biotechnology
2020
Registration and Stockholder Rights Agreement, dated July 7, 2020, by and among the Company, Therapeutics Acquisition Holdings, LLC and the other holders party thereto
Registration Rights Agreements
Therapeutics Acquisition Corp.
Biotechnology
NY
2020
Private Placement Class A Common Stock Purchase Agreement, dated July 7, 2020 by and among the Company and Therapeutics Acquisition Holdings, LLC
Stock Agreements
Therapeutics Acquisition Corp.
2020
Private Placement Class A Common Stock Purchase Agreement, dated July 8, 2020 by and among the Company and Therapeutics Acquisition Holdings, LLC
Stock Agreements
Therapeutics Acquisition Corp.
2020
Letter Agreement, dated July 7, 2020, by and among the Company, its officers, its directors and Therapeutics Acquisition Holdings, LLC
Therapeutics Acquisition Corp.
2020
Form of Underwriting Agreement
Underwriting Agreements
Therapeutics Acquisition Corp.
Biotechnology
DE
2020
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant
Stock Agreements
Therapeutics Acquisition Corp.
2020
Form of Registration and Stockholder Rights Agreement among the Registrant and the Holders of the Founder Shares and Private Placement Shares
Registration Rights Agreements
Therapeutics Acquisition Corp.
Biotechnology
NY
2020
Form of Letter Agreement among the Registrant and each director and executive officer of the Registrant
Therapeutics Acquisition Corp.
2020
Form of Private Placement Class A Common Stock Purchase Agreement between the Registrant and our Sponsor
Stock Agreements
Therapeutics Acquisition Corp.
2020
Form of Underwriting Agreement
Underwriting Agreements
Therapeutics Acquisition Corp.
Biotechnology
DE
2020
Specimen Unit Certificate
Therapeutics Acquisition Corp.
2020
Specimen Common Stock Certificate
Stock Agreements
Therapeutics Acquisition Corp.
2020
Specimen Warrant Certificate
Warrant Agreements
Therapeutics Acquisition Corp.
Biotechnology
2020
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant
Warrant Agreements
Therapeutics Acquisition Corp.
Biotechnology
NY
2020
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant
Stock Agreements
Therapeutics Acquisition Corp.
2020
Form of Registration and Stockholder Rights Agreement among the Registrant and the Sponsor
Registration Rights Agreements
Therapeutics Acquisition Corp.
2020
Form of Indemnity Agreement
Therapeutics Acquisition Corp.
2020
Form of Letter Agreement among the Registrant and each director and executive officer of the Registrant
Therapeutics Acquisition Corp.
Biotechnology
2020
Form of Subscription Agreement between the Registrant and our Sponsor
Subscription Agreements
Therapeutics Acquisition Corp.
Biotechnology
DE
2020
Form of Private Placemenet Warrants Purchase Agreement between the Registrant and our Sponsor
Purchase Agreements
Therapeutics Acquisition Corp.
2020